SCHEMBL485579

SCHEMBL485579

O=C(NC1CCCC1)c1ccc2ccccc2c1OCc1ccc(C(F)(F)F)nc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR2 P25025 1/20 0.47
CNR2 P34972 7/20 0.47
CNR1 P21554 6/20 0.47
ALDH1A1 P00352 2/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
SGMS2 Q8NHU3 1/20 0.44
DRD4 P21917 2/20 0.44
CYP3A4 P08684 1/20 0.44
CYP3A5 P20815 1/20 0.44
KDM4E B2RXH2 1/20 0.41
NPC1 O15118 1/20 0.41
NR1I2 O75469 1/20 0.41
HPGD P15428 1/20 0.41
AHR P35869 1/20 0.41
HTT P42858 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
MAOB P27338 1/20 0.41
MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL485790 0.98 CXCR2 (0.47) CXCR2CNR2CNR1ALDH1A1MEN1
SCHEMBL485511 0.86 CXCR2 (0.62) CXCR2CNR2CNR1ALDH1A1MEN1
SCHEMBL485840 0.86 MRGPRX4 (0.47) CNR2CNR1ALDH1A1MEN1KMT2A
SCHEMBL485784 0.85 CXCR2 (0.44) CXCR2CNR2CNR1ALDH1A1MEN1
SCHEMBL485699 0.84 CXCR2 (0.62) CXCR2CNR2CNR1ALDH1A1MEN1
SCHEMBL1598461 0.83 CXCR2 (0.49) CXCR2ALDH1A1KDM4EHTTSMN1; SMN2
SCHEMBL485551 0.83 ALDH1A1 (0.49) CXCR2CNR2CNR1ALDH1A1MEN1
SCHEMBL485837 0.82 ALDH1A1 (0.48) CXCR2CNR2CNR1ALDH1A1MEN1
SCHEMBL485254 0.82 CXCR2 (0.59) CXCR2ALDH1A1CYP3A4KDM4EHTT
SCHEMBL485075 0.82 CXCR2 (0.56) CXCR2ALDH1A1KDM4EHTTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1836158-B1 FUSED BICYCLIC CARBOXAMIDE DERIVATIVES FOR USE AS CXCR2 INHIBITORS IN THE TREATMENT OF INFLAMMATION SANOFI AVENTIS DEUTSCHLAND (DE) 2012-02-01 EP claimed